Bardin Hill Management Partners LP Buys 157,338 Shares of Enhabit, Inc. (NYSE:EHAB)

Bardin Hill Management Partners LP increased its position in Enhabit, Inc. (NYSE:EHAB - Free Report) by 927.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 174,304 shares of the company's stock after acquiring an additional 157,338 shares during the quarter. Enhabit comprises about 0.6% of Bardin Hill Management Partners LP's holdings, making the stock its 25th biggest holding. Bardin Hill Management Partners LP owned 0.35% of Enhabit worth $1,377,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. DekaBank Deutsche Girozentrale lifted its position in Enhabit by 39.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 340,412 shares of the company's stock valued at $3,861,000 after purchasing an additional 95,488 shares during the last quarter. WINTON GROUP Ltd bought a new stake in Enhabit during the second quarter valued at approximately $955,000. Marshall Wace LLP bought a new stake in Enhabit during the second quarter valued at approximately $1,941,000. AREX Capital Management LP lifted its position in Enhabit by 2.5% during the second quarter. AREX Capital Management LP now owns 2,472,662 shares of the company's stock valued at $22,056,000 after purchasing an additional 59,353 shares during the last quarter. Finally, Gladius Capital Management LP bought a new stake in Enhabit during the second quarter valued at approximately $31,000.

Enhabit Trading Up 1.2 %

Shares of NYSE EHAB traded up $0.09 during mid-day trading on Monday, hitting $7.82. The stock had a trading volume of 179,282 shares, compared to its average volume of 576,624. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. Enhabit, Inc. has a 1 year low of $6.85 and a 1 year high of $11.74. The business has a 50 day moving average price of $7.46 and a two-hundred day moving average price of $8.35. The firm has a market cap of $393.22 million, a P/E ratio of -3.33 and a beta of 1.84.

Enhabit (NYSE:EHAB - Get Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The firm had revenue of $253.60 million during the quarter, compared to analysts' expectations of $261.69 million. During the same period in the previous year, the firm earned $0.03 earnings per share. On average, equities analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Leerink Partners reiterated a "market perform" rating and set a $8.00 target price (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One analyst has rated the stock with a sell rating and six have issued a hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $9.25.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.